Indication

Chronic hepatitis C - genotype 6

Chronic hepatitis C – genotype 6 is a persistent liver infection characterized by detectable hepatitis C viral RNA for at least six months, specifically caused by genotype 6 of the single-stranded RNA hepatitis C virus. Read more about Chronic hepatitis C - genotype 6

6 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis C - genotype 6 therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis C - genotype 6 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis C - genotype 6.

Chronic hepatitis C – genotype 6 is a persistent liver infection characterized by detectable hepatitis C viral RNA for at least six months, specifically caused by genotype 6 of the single-stranded RNA hepatitis C virus.

Primarily endemic to Southeast Asia and southern China, this subtype targets the hepatic system and frequently demonstrates marked genetic diversity across its recognized subtypes.

Pathophysiologically, persistent intrahepatic viral replication and host immune-mediated inflammation drive progressive hepatocellular injury, which can advance silently over decades to hepatic fibrosis, cirrhosis, end-stage liver disease, and hepatocellular carcinoma.

Personalize your experience

Follow Chronic hepatitis C - genotype 6 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it